Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI

This release has been updated: MAR Tag Added UPPSALA, SE / ACCESS Newswire / June 30, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, specializing in blood-based cancer monitoring, today announces that it has, by mutual …